InvestorsHub Logo
Followers 47
Posts 12038
Boards Moderated 0
Alias Born 09/12/2017

Re: WaveSlaveDave post# 106224

Friday, 08/14/2020 10:27:29 PM

Friday, August 14, 2020 10:27:29 PM

Post# of 232963
The Company’s inventory as of May 31, 2020 and May 31, 2019 was $19,146,678 and $0, respectively. Inventory as of May 31, 2020 consisted of raw materials purchased for use in the commercial manufacturing of pre-launch inventories of leronlimab to support the Company’s expected approval of the product as a combination therapy for HIV patients in the United States
https://www.sec.gov/Archives/edgar/data/1175680/000119312520220598/d923315d10k.htm

The Company’s inventory as of February 29, 2020 and May 31, 2019 was $15,895,589 and $0, respectively. Inventory as of February 29, 2020 consisted solely of specialized raw material purchased for use in the commercial manufacturing of pre-launch inventories of Vyrologix to support the Company’s expected approval of the product as a combination therapy for HIV patients in the United States
https://www.sec.gov/Archives/edgar/data/1175680/000119312520102675/d859184d10q.htm

LOL! "raw materials" increased by $3,251,089 in 3 months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News